Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Merck $6 billion notes offering
The investment-grade notes offering consists of six tranches
Bruker mandatory convertible preferred stock offering
The preferred stock will be listed on Nasdaq
Precigen $125 million financing
We advised Precigen on the loan agreement
Ascletis HK$861.98 million placement of shares and top-up subscription
We advised the placing agent on the placement and the top-up subscription
Cardinal Health $1 billion notes offering
The investment-grade notes are due 2030 and 2035
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Zoetis $1.85 billion senior notes offering
The investment-grade notes are due 2028 and 2035
Tempus AI $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Amneal Pharmaceuticals $600 million notes offering
We advised Amneal Pharmaceuticals on its high-yield notes offering